Patent · US Active

Antibody-mediated immunocontraception

US10570200B2 · kind B2 · utility

3Cited by
20References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 31, 2014
Grant dateFeb 25, 2020
Priority date—
Expiry dateJan 27, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure generally relates to methods and compositions for contraception. In some embodiments, vector based approaches for contraception are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.